Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clarivate (CLVT) Gains from Investment Securities (2017 - 2025)

Clarivate (CLVT) has disclosed Gains from Investment Securities for 8 consecutive years, with $23.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities fell 53.77% year-over-year to $23.9 million, compared with a TTM value of -$3.2 million through Dec 2025, down 120.51%, and an annual FY2025 reading of -$3.2 million, down 120.51% over the prior year.
  • Gains from Investment Securities was $23.9 million for Q4 2025 at Clarivate, up from $18.7 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $113.4 million in Q4 2021 and bottomed at -$264.3 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is -$20.7 million, with a median of -$6.3 million recorded in 2023.
  • Peak annual rise in Gains from Investment Securities hit 328.63% in 2021, while the deepest fall reached 1678.98% in 2021.
  • Year by year, Gains from Investment Securities stood at $113.4 million in 2021, then tumbled by 333.05% to -$264.3 million in 2022, then soared by 87.63% to -$32.7 million in 2023, then skyrocketed by 258.1% to $51.7 million in 2024, then plummeted by 53.77% to $23.9 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CLVT at $23.9 million in Q4 2025, $18.7 million in Q3 2025, and -$52.2 million in Q2 2025.